Basic Information
Basic information for C21orf62-AS1-209-66aa
Peptide Name C21orf62-AS1-209-66aa
Genome Position chr21:32788296-32788493[+]
Species Human
Peptide Sequence MRFGCGTAKPYQTLLNEKASVHHYSCNKSHPIYKCSVNSGETEALKLFVSKSGKWKWRFQFLFLLI
Peptide Length 66
Unique Yes
Grand Average of Hydropathicity -0.2879
Relative Molecular Mass 8827
Experimental Evidences no
lncRNA ID/Name ENSG00000205930;C21orf62-AS1
Transcript ID/Name ENST00000655231;C21orf62-AS1-209
Transcript Length 5020
Coding Ability 0.506
DNA Sequence Corresponding to Peptide ATGAGATTTGGGTGTGGCACAGCCAAACCATATCAGACTCTGTTAAATGAAAAAGCCTCCGTACATCATTATTCTTGTAACAAATCACATCCAATTTACAAGTGTTCTGTAAATTCTGGAGAAACAGAGGCCCTGAAGTTATTCGTGAGCAAGTCTGGGAAATGGAAATGGAGGTTCCAATTCCTGTTTTTACTAATT
Experimental Evidences
Conservation
   Conservation
Peptide-MHC I binding
   Peptide-MHC I binding
Peptide-MHC II binding
   Peptide-MHC II binding
Spatial Expression
   Spatial Expression
Source :   
Clinical Relevance
   Clinical Relevance
Source :   
Cancer :